Drugs / SUPREP
SUPREP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT04504292 | Aug 2020 → May 2021 | — | University of Virginia | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 4 | NCT04758156 Comparator | Aug 2019 → Jul 2021 | colon adenoma, polyp of colon | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01719653 Comparator | Oct 2012 → Sep 2014 | — | Gastroenterology Services, Ltd. | Completed | No outcome recorded |
| — | NCT02481219 Comparator | May 2015 → Jan 2016 | colorectal cancer | Medtronic - MITG | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SUPREP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04504292 ↗ |
| Known as | SUPREP Bowel Prep Kit | “Drug: SUPREP Bowel Prep Kit” NCT04504292 ↗ |
| Known as | SUPREP oral sulfate solution | “2 SUPREP oral sulfate solution” NCT02481219 ↗ |
| Route | Oral | “2 SUPREP oral sulfate solution” NCT02481219 ↗ |